29th -30th September 2020

MarketsandMarkets Biosimilars Virtual Conference

The Biosimilars industry is experiencing significant growth due to the rising incidence of chronic diseases and the increasing demand for biosimilars due to their cost-effectiveness.

The global biosimilars market size is expected to grow from USD 35.7 billion by 2025 from USD 11.8 billion in 2020, at a CAGR of 24.7%. However, with complexities in manufacturing and resistance from biologic manufacturers, such factors keeps adding to the hinderance in their development.

MarketsandMarkets Biosimilars- Digital Conference presents to you a virtual platform to keep your scientific exchange live. The online conference will hold discussions on key clinical attributes of biosimilars, perspectives from different stakeholders regarding opportunities for the biosimilar market, and how intense can the competition get.

The conference will also address the perspective on the global regulatory landscape and how partnerships can highly support R&D and the production of biosimilars.

Witness discussions on the importance of market access and marketing strategy and how should companies enhance their presence in the market.

WHAT TO EXPECT
Key Highlights
  • Strategic framework and regulatory considerations
  • Key clinical attributes of Biosimilars
  • Expectations of biosimilars by different stakeholders
  • Market access and commercialization
Who Should Attend?

CEO, CSO, CMO, Director, VP, Head, Manager, and Research fellows from pharmaceutical and biotech company working in:

  • Biosimilar Research
  • Biosimilar Development
  • Clinical Development Unit
  • Regulatory Affairs
  • Medical Affairs and information
  • Scientific Affairs
  • Legal Affairs
  • Market Access
  • Licensing
  • Pricing strategy
  • Clinical Pharmacology
  • Clinical affairs/clinical operations
  • Commercial Development
  • Bioanalytics
Why Attend?
  • Learn about the recent trends and advancements affecting the biosimilars market
  • Learn about best practices for the commercial structure of a biosimilar from development to market access strategy
  • Engage in meaningful discussion with the most prominent industry experts and decision-makers from pharmaceutical and biopharmaceutical manufactures who will address most critical challenges in biosimilars upstream and downstream process
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading manufacturers, global regulators, and solution providers
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Michelle Bridenbaker

Michelle Bridenbaker

Senior Director, Global Medical Information Neuroscience and Biosimilars
Biogen

Michelle Bridenbaker

Senior Director, Global Medical Information Neuroscience and Biosimilars
Biogen
Giuseppe Curigliano

Giuseppe Curigliano

Clinical Director,Division of Early Drug Development for Innovative Therapy, Co-Chair Cancer Experimental Therapeutics Program, Department of Oncology and Hemato-Oncology,
University of Milan, European Institute of Oncology

Giuseppe Curigliano

Clinical Director,Division of Early Drug Development for Innovative Therapy, Co-Chair Cancer Experimental Therapeutics Program, Department of Oncology and Hemato-Oncology,
University of Milan, European Institute of Oncology
Sarfaraz K. Niazi

Sarfaraz K. Niazi

Professor Adjunct of Biopharmaceutical Sciences
University of Illinois at Chicago

Sarfaraz K. Niazi

Professor Adjunct of Biopharmaceutical Sciences
University of Illinois at Chicago
Sweety Mathew

Sweety Mathew

Regulatory Affairs
Biocon

Sweety Mathew

Regulatory Affairs
Biocon
Scott Soefje

Scott Soefje

Director, Pharmacy Cancer Care, Department of Pharmacy, Assistant Professor of Pharmacy
Mayo Clinic College of Medicine and Science

Scott Soefje

Director, Pharmacy Cancer Care, Department of Pharmacy, Assistant Professor of Pharmacy
Mayo Clinic College of Medicine and Science
Miguel Navarrete

Miguel Navarrete

Hospital & Biosimilars Commercial Director
STADA

Miguel Navarrete

Hospital & Biosimilars Commercial Director
STADA
Piercarlo Sarzi-Puttini

Piercarlo Sarzi-Puttini

Director Rheumatology Unit, L. Sacco University Hospital & Professor of Rheumatology,
University of Milan, Italy

Piercarlo Sarzi-Puttini

Director Rheumatology Unit, L. Sacco University Hospital & Professor of Rheumatology,
University of Milan, Italy
Vimal Sachdeva

Vimal Sachdeva

Technical Officer (Senior Inspector), Regulation and Prequalification Department (RPQ)
World Health Organization (WHO)

Vimal Sachdeva

Technical Officer (Senior Inspector), Regulation and Prequalification Department (RPQ)
World Health Organization (WHO)
PAST EVENT GALLERY